Literature DB >> 8923529

A stress-sensitive chemokinergic neuronal pathway in the hypothalamo-pituitary system.

Y Sakamoto1, K Koike, H Kiyama, K Konishi, K Watanabe, S Tsurufuji, R J Bicknell, K Hirota, A Miyake.   

Abstract

Recently we found that cytokine-induced neutrophil chemoattractant influenced anterior pituitary hormone release in vitro. These observations prompted us to investigate the possibility of the existence of cytokine-induced neutrophil chemoattractant in the hypothalamus. Immunohistochemistry showed that cytokine-induced neutrophil chemoattractant-like immunoreactivity existed in the paraventricular hypothalamic nucleus, the supraoptic nucleus, both the internal and the external layers of the median eminence and the posterior pituitary. Since the paraventricular hypothalamic nucleus plays a pivotal role in response to stressful stimuli, we examined the effect of a single episode of immobilization stress on cytokine-induced neutrophil chemoattractant messenger RNA expression in the paraventricular hypothalamic nucleus. Immobilization stress induced strong hybridization signals of cytokine-induced neutrophil chemoattractant messenger RNA in the parvocellular and magnocellular subdivision of the paraventricular hypothalamic nucleus within 15 min, and cytokine-induced neutrophil chemoattractant-like immunostaining intensity in the posterior pituitary started to increase around the periphery of the posterior lobe at 30 min after stress and extended to the whole lobe at 1 h after stress. The increase in the serum cytokine-induced neutrophil chemoattractant in response to stress showed a kinetically biphasic pattern. A first phase occurred within 15 min which may be due to an immediate release of stored cytokine-induced neutrophil chemoattractant in the neurohypophysis, since hypophysectomy completely blocked this phase. A second phase may reflect the release of newly synthesized cytokine-induced neutrophil chemoattractant in the paraventricular hypothalamic nucleus and/or peripheral cytokine-induced neutrophil chemoattractant, since hypophysectomy could not reduce this phase. These data suggest that cytokine-induced neutrophil chemoattractant in the paraventricular hypothalamic nucleus was immediately synthesized in response to stress, and then released into the peripheral blood via the hypothalamo-neurohypophysial system, revealing the presence of a stress-sensitive chemokinergic neuronal pathway in the hypothalamo-pituitary system.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8923529     DOI: 10.1016/0306-4522(96)00252-7

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  5 in total

1.  Chronic intermittent cold stress sensitizes neuro-immune reactivity in the rat brain.

Authors:  Milena Girotti; Jennifer J Donegan; David A Morilak
Journal:  Psychoneuroendocrinology       Date:  2011-03-15       Impact factor: 4.905

2.  Restraint stress alters neutrophil and macrophage phenotypes during wound healing.

Authors:  Stéphanie D Tymen; Isolde G Rojas; Xiaofeng Zhou; Zong Juan Fang; Yan Zhao; Phillip T Marucha
Journal:  Brain Behav Immun       Date:  2012-08-03       Impact factor: 7.217

3.  Evidence of different mediators of central inflammation in dysfunctional and inflammatory pain--interleukin-8 in fibromyalgia and interleukin-1 β in rheumatoid arthritis.

Authors:  Eva Kosek; Reem Altawil; Diana Kadetoff; Anja Finn; Marie Westman; Erwan Le Maître; Magnus Andersson; Mats Jensen-Urstad; Jon Lampa
Journal:  J Neuroimmunol       Date:  2015-02-19       Impact factor: 3.478

Review 4.  A Potential Contribution of Chemokine Network Dysfunction to the Depressive Disorders.

Authors:  Joanna Ślusarczyk; Ewa Trojan; Jakub Chwastek; Katarzyna Głombik; Agnieszka Basta-Kaim
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363

Review 5.  The Role of Chemokines in the Pathophysiology of Major Depressive Disorder.

Authors:  Vladimir M Milenkovic; Evan H Stanton; Caroline Nothdurfter; Rainer Rupprecht; Christian H Wetzel
Journal:  Int J Mol Sci       Date:  2019-05-09       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.